These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31415873)

  • 1. Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model.
    Chai G; Park H; Yu S; Zhou F; Li J; Xu Q; Zhou QT
    Int J Pharm; 2019 Oct; 569():118616. PubMed ID: 31415873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of inhalable liposomal powder formulations and evaluation of their in vitro drug delivery behavior in Calu-3 human lung epithelial cells.
    Yu S; Yuan H; Chai G; Peng K; Zou P; Li X; Li J; Zhou F; Chan HK; Zhou QT
    Int J Pharm; 2020 Aug; 586():119570. PubMed ID: 32593649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.
    Yu S; Wang S; Zou P; Chai G; Lin YW; Velkov T; Li J; Pan W; Zhou QT
    Int J Pharm; 2020 Feb; 575():118915. PubMed ID: 31816354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal Formulation Reduces Transport and Cell Uptake of Colistin in Human Lung Epithelial Calu-3 Cell and 3D Human Lung Primary Tissue Models.
    Huang Y; Yu S; Ahmed MU; Zhou QT
    AAPS PharmSciTech; 2024 Feb; 25(3):40. PubMed ID: 38366100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.
    Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G
    Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of drug delivery behavior for inhalable amorphous nanoparticle formulations in a human lung epithelial cell model.
    Chen J; Ahmed MU; Zhu C; Yu S; Pan W; Velkov T; Li J; Tony Zhou Q
    Int J Pharm; 2021 Mar; 596():120211. PubMed ID: 33486036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Delivery of Ciprofloxacin and Colistin in Liposomal Formulations with Enhanced In Vitro Antimicrobial Activities against Multidrug Resistant Pseudomonas aeruginosa.
    Wang S; Yu S; Lin Y; Zou P; Chai G; Yu HH; Wickremasinghe H; Shetty N; Ling J; Li J; Zhou QT
    Pharm Res; 2018 Aug; 35(10):187. PubMed ID: 30094660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrostatically entrapped colistin liposomes for the treatment of Pseudomonas aeruginosa infection.
    Li Y; Tang C; Zhang E; Yang L
    Pharm Dev Technol; 2017 May; 22(3):436-444. PubMed ID: 27576012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
    Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O
    Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
    J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
    D'Souza BB; Padmaraj SR; Rekha PD; Tellis RC; Prabhu S; Pothen P
    Microb Drug Resist; 2014 Dec; 20(6):550-4. PubMed ID: 25055029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa.
    Yu S; Pu X; Ahmed MU; Yu HH; Mutukuri TT; Li J; Zhou QT
    Int J Pharm; 2021 Dec; 610():121160. PubMed ID: 34624446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa.
    Yamagishi Y; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Nakai H; Mikamo H
    Chemotherapy; 2017; 62(2):105-110. PubMed ID: 27788502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro lung epithelial cell transport and anti-interleukin-8 releasing activity of liposomal ciprofloxacin.
    Darweesh RS; Sakagami M
    Eur J Pharm Sci; 2018 Mar; 115():68-76. PubMed ID: 29337216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aerosolized colistin on multidrug-resistant Pseudomonas aeruginosa in bronchial secretions of patients without cystic fibrosis.
    Horianopoulou M; Lambropoulos S; Papafragas E; Falagas ME
    J Chemother; 2005 Oct; 17(5):536-8. PubMed ID: 16323443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hetero-Multivalent Targeted Liposomal Drug Delivery to Treat
    Singla A; Simbassa SB; Chirra B; Gairola A; Southerland MR; Shah KN; Rose RE; Chen Q; Basharat A; Baeza J; Raina R; Chapman MJ; Hassan AM; Ivanov I; Sen A; Wu HJ; Cannon CL
    ACS Appl Mater Interfaces; 2022 Sep; 14(36):40724-40737. PubMed ID: 36018830
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.
    Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Chan HK
    Int J Pharm; 2018 Nov; 551(1-2):158-165. PubMed ID: 30223075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.
    Taccetti G; Bianchini E; Cariani L; Buzzetti R; Costantini D; Trevisan F; Zavataro L; Campana S;
    Thorax; 2012 Oct; 67(10):853-9. PubMed ID: 22379071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.